{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":3,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":3,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"ee0a2d82d17d","filters":{"venue":"Zhongguo aizheng zazhi"}},"results":[{"id":"W2372010367","doi":"","title":"BCL-6,CD10 and BCL-2 protein expression in B-cell Non-Hodgkin's lymphoma and its clinicopathologic significance","year":2006,"lang":"en","type":"article","venue":"Zhongguo aizheng zazhi","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"L'Alliance Boviteq","funders":"","keywords":"Lymphoma; Germinal center; Mantle cell lymphoma; Lymphoid hyperplasia; Pathology; Mantle zone; Follicular lymphoma; Diffuse large B-cell lymphoma; MALT lymphoma; Follicular hyperplasia; Marginal zone; B cell; Lymphoplasmacytic Lymphoma; Lymph node; Immunohistochemistry; Medicine; Cancer research; Antibody; Immunology; Waldenstrom macroglobulinemia","authors":[{"name":"Daren Shi","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01152292866227459,"gpt":0.2502943782376759,"spread":0.2387714495754013,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004709515,0.0001274279,0.00007123469,0.0009579354,0.0001482593,0.0001798478,0.0001458749,0.000173312,0.0006242147],"category_scores_gemma":[0.0005043146,0.0001166103,0.00006793719,0.0003744815,0.0003958453,0.0002343815,0.0001254671,0.0001001021,0.000096698],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000212676,"about_ca_system_score_gemma":0.0001239729,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001056912,"about_ca_topic_score_gemma":0.001275166,"domain_scores_codex":[0.9998941,0.00002471182,0.00001144279,0.00001682639,0.000031127,0.00002173749],"domain_scores_gemma":[0.999792,0.00005457351,0.00006819049,0.0000119974,0.0000349579,0.00003829651],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002948586,0.00003303868,0.9554327,0.00007474542,0.00002578186,0.003184069,0.0002578217,0.00008495386,0.03000145,0.00007677247,0.000124285,0.01040961],"study_design_scores_gemma":[0.00003110218,0.0001656554,0.968212,0.00001755389,0.00005451507,0.02335855,0.0003477244,0.0005097971,0.005436459,0.0001386772,0.0017207,0.000007305084],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986323,0.0009404875,0.00008020591,0.00001458648,0.000002209179,0.000002766037,0.0000142971,0.000003105567,0.0003099874],"genre_scores_gemma":[0.9995211,0.0002454994,0.00006952367,0.000004666163,0.000004580513,0.00000311475,0.00002920209,4.914072e-7,0.0001217842],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001056912,"threshold_uncertainty_score":0.00249064,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2353777016","doi":"","title":"Expression of MEK-1 in regulation of αV integrin and E-cadherin of MCF-7 breast cancer cells","year":2003,"lang":"en","type":"article","venue":"Zhongguo aizheng zazhi","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Northeast Cancer Centre","funders":"","keywords":"MEK inhibitor; Integrin; MAPK/ERK pathway; Cadherin; MCF-7; Phosphorylation; Cell biology; Transfection; Chemistry; Cancer research; Molecular biology; Cancer cell; Biology; Cell; Cancer; Gene; Biochemistry; Human breast; Genetics","authors":[{"name":"Zhang Lian-feng","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007577277868354109,"gpt":0.2218931008747687,"spread":0.2143158230064146,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006304268,0.0002567091,0.0001068276,0.0001155885,0.0001324632,0.0001802537,0.0001168568,0.0001362782,0.0008891883],"category_scores_gemma":[0.00005076347,0.0001028464,0.0001490117,0.00005761027,0.00009696263,0.0001109327,0.00009684693,0.0003445016,0.0002874917],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000307069,"about_ca_system_score_gemma":0.0001573936,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006815406,"about_ca_topic_score_gemma":0.001060754,"domain_scores_codex":[0.999934,0.00000864814,0.000004542046,0.00001062671,0.00001975696,0.00002243632],"domain_scores_gemma":[0.9999756,0.000004204945,0.000005404944,0.000002759765,0.000005295441,0.000006918331],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00005920575,0.00001683305,0.0001538474,0.00002971495,0.000001860005,0.0000287893,0.000009044097,0.00003419391,0.9987167,0.0001282488,0.00003230432,0.0007891744],"study_design_scores_gemma":[0.00001406958,0.0001242872,0.003481225,0.000005402536,0.00001100847,0.0001858245,0.00002328979,0.0008303303,0.9924812,0.00004381983,0.002797333,0.000002268644],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933978,0.002149457,0.001494295,0.0001279509,0.00002683096,0.00001710723,0.0002129449,0.00004057362,0.002532968],"genre_scores_gemma":[0.9936646,0.001123459,0.001393881,0.00003867487,0.000004654704,0.00002005083,0.0003883594,0.00000676668,0.003359602],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008891883,"threshold_uncertainty_score":0.002974629,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2380392281","doi":"","title":"Novel therapeutic strategies for advanced pancreatic cancer: targeting the epidermal growth factor and vascular endothelial growth factor pathways","year":2009,"lang":"en","type":"article","venue":"Zhongguo aizheng zazhi","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Erlotinib; Medicine; Gemcitabine; Bevacizumab; Pancreatic cancer; Vascular endothelial growth factor; Oncology; Cetuximab; Epidermal growth factor receptor; Sunitinib; Internal medicine; Sorafenib; EGFR inhibitors; Epidermal growth factor; Gefitinib; Cancer; Pharmacology; Chemotherapy; Hepatocellular carcinoma; Colorectal cancer; Receptor","authors":[{"name":"LU Jia-de","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04308598512289617,"gpt":0.3199233937482674,"spread":0.2768374086253713,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005454152,0.000392232,0.000495259,0.0008822805,0.0001825707,0.0006337705,0.0003480726,0.000562345,0.002658657],"category_scores_gemma":[0.0002170424,0.000109853,0.0003981283,0.0004021912,0.000445208,0.0009527435,0.0004099075,0.0009419332,0.0004698526],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004292531,"about_ca_system_score_gemma":0.0004206113,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002743095,"about_ca_topic_score_gemma":0.0009904957,"domain_scores_codex":[0.9999048,0.00003358761,0.000007635315,0.00001395308,0.00002285544,0.00001723312],"domain_scores_gemma":[0.9999284,0.00002558975,0.00001586477,0.000003860922,0.00001148905,0.00001494563],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.0006546468,0.0008357008,0.001153614,0.004853313,0.0001290854,0.00199379,0.0001880853,0.00102938,0.0556024,0.008623593,0.006238774,0.9186975],"study_design_scores_gemma":[0.002701522,0.007037706,0.01518067,0.002444849,0.0009081372,0.02214045,0.0008313659,0.002669668,0.07341631,0.01997413,0.8525829,0.0001122484],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.03493331,0.940969,0.008261146,0.00570012,0.0005939517,0.000133021,0.00004615496,0.00006334336,0.009300013],"genre_scores_gemma":[0.1628072,0.8157857,0.01226074,0.001978396,0.0008493375,0.0001607581,0.0001129899,0.00001319414,0.006031669],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.002658657,"threshold_uncertainty_score":0.008894145,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}